SINGULAR GENOMICS SYSTEMS IN (OMIC) Earnings History & Surprises

NASDAQ:OMICUS82933R3084

Current stock price

20.01 USD
+0.05 (+0.25%)
Last:

OMIC Earnings overview

Past quarterly earnings results for SINGULAR GENOMICS SYSTEMS IN (OMIC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 17, 2025
Period
Q4 / 2024
EPS Estimate
-$8.13
Revenue Estimate
1.208M

Last Reported

Most Recent
Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Reported
-$6.72
EPS Surprise
18.16%
Revenue Surprise
-51.75%

Beat Rate

Last 8 Quarters
69%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2024 -6.72 -8.21 18.16% 27.74% 406K 841.5K -51.75% -12.12%
Q2 2024 -8.57 -9.04 5.17% 18.38% 737K 408K 80.64% 45.94%
Q1 2024 -10.20 -10.71 4.76% -3.03% 442K 401.88K 9.98% -48.78%
Q4 2023 -9.60 -10.51 8.62% -10.34% 1.081M 745.957K 44.91% 40.39%
Q3 2023 -9.30 -11.63 20.02% 6.06% 462K 1.3M -64.46% -
Q2 2023 -10.50 -11.32 7.26% -2.94% 505K 1.174M -56.98% -
Q1 2023 -9.90 -10.83 8.61% -6.45% 863K 1.267M -31.89% -
Q4 2022 -8.70 -13.04 33.26% -7.41% 770K 774.996K -0.64% -
Q3 2022 -9.90 -12.67 21.85% -32.00% 76.5K -100.00% -
Q2 2022 -10.20 -11.75 13.19% 20.93% 51K -100.00% -
Q1 2022 -9.30 -10.20 8.82% - - -
Q4 2021 -8.10 -9.42 14.06% - - -
Q3 2021 -7.50 -7.34 -2.12% - - -
Q2 2021 -12.90 -6.22 -107.33% - - -
Q1 2021 - - - -
Q4 2020 - - - -
Q3 2020 - - - -
Q2 2020 - - - -
Q1 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

OMIC EPS Q2Q GrowthOMIC EPS Q2Q GrowthEPS Q2Q Growth Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 0 20 -20 40 60 80

Revenue Historical Q2Q growth and Acceleration

OMIC Revenue Q2Q GrowthOMIC Revenue Q2Q GrowthRevenue Q2Q Growth Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 200 400 600 800 1K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
9.18%
Max EPS beat (4)
18.16%
Min EPS beat (4)
4.76%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
20.95%
Max Revenue beat (4)
80.64%
Min Revenue beat (4)
-51.75%

Analysis

In the last 4 quarters, OMIC has consistently beaten EPS estimates in all releases
OMIC has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, OMIC has beaten the EPS estimates by 9.2% on average.
In the last 4 quarters, OMIC has beaten the revenue estimates by 20.9% on average.

SINGULAR GENOMICS SYSTEMS IN / OMIC Earnings FAQ

When did SINGULAR GENOMICS SYSTEMS IN (OMIC) report earnings last quarter?

SINGULAR GENOMICS SYSTEMS IN (OMIC) last reported earnings on 11/12/2024.

Did OMIC stock beat earnings estimates in the most recent quarter?

SINGULAR GENOMICS SYSTEMS IN (OMIC) beat EPS estimates and missed revenue estimates in the most recent quarter.

How often does SINGULAR GENOMICS SYSTEMS IN (OMIC) beat earnings estimates?

In the last 4 quarters, SINGULAR GENOMICS SYSTEMS IN (OMIC) has beaten EPS estimates in 4 out of 4 releases.